RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 51322-75-9:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- WITH THERAPEUTIC USE
- Tizanidine, an imidazole derivative, is a centrally acting alpha-2 adrenergic agonist structurally related to clonidine, but possesses only 1/10 to 1/50 of clonidine's potency. It may also be selective for imidazoline-receptors. It has been reported that tizanidine 12 mg has sedative and sympatholytic effects comparable with clonidine 150 micrograms. Dry mouth, somnolence, asthenia, dizziness and mild hypotension are common adverse effects following the therapeutic use of tizanidine. Bradycardia, palpitations, ventricular extrasystoles, rash, sweating, skin ulcer, pruritus, nausea, vomiting, dyspepsia, abdominal pain, diarrhea, constipation, elevated liver enzymes, back pain, lethargy, drowsiness, insomnia, headache, anxiety, syncope, tremor, depression, weakness, paresthesia, visual hallucinations, and fever are uncommon adverse effects.
- WITH POISONING/EXPOSURE
- Following an overdose, tizanidine may cause alterations of mental status, lethargy, bradycardia, hypotension, agitation, confusion, drowsiness, vomiting, miosis, coma, or respiratory depression. Sinus bradycardia (HR 34 beats/minute), first degree AV block, and Wenckebach type second degree AV block were reported in a woman who ingested 120 mg tizanidine and 30 mg lorazepam.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.